AD/PD™ International Conference
We invite you to join us at the upcoming AD/PD™ 2024 International Conference on Alzheimer’s and Parkinson’s Diseases and related neurological disorders in Lisbon or online on March 5-9, 2024.
Register today at https://adpd.kenes.com/
AD/PD™ 2023
AD/PD™ International Conference
Immunotherapy of Alzheimer’s Disease by Modulation of Innate Immunity
FEATURING
Howard L. Weiner
- 344 views
- October 24, 2023
AD/PD™ International Conference
New Insight In The Treatment of Parkinson's Disease
FEATURING
Fabrizio Stocchi
- 158 views
- October 23, 2023
AD/PD™ International Conference
Phase 1 First-In-Man Clinical Trial of Intraputamenal CDNF in Parkinson’s Disease
FEATURING
Per Svenningsson
- 119 views
- October 23, 2023
AD/PD™ International Conference
Nation-Wide Registry’s Real-Life Data on Levodopa-Entacapone-Carbidopa Intestinal Gel In Parkinson’s Disease
FEATURING
Dag Nyholm
- 54 views
- October 23, 2023
AD/PD™ International Conference
Alzheimer’s Disease and Immunotherapy
FEATURING
Beka Solomon
- 40 views
- October 23, 2023
AD/PD™ International Conference
Preclinical Evaluation of Novel Glutathione Analog as a Disease Modifying Therapy For Alzheimer’s Disease
FEATURING
Michael Lee
- 23 views
- October 23, 2023
AD/PD™ International Conference
Novel Therapies Of Familial Alzheimer’s Disease
FEATURING
Jie Shen
- 41 views
- October 23, 2023
AD/PD™ International Conference
Harnessing The Physiological Functions Of APP For AD Treatment
FEATURING
Ulrike C. Müller
- 7 views
- October 23, 2023
AD/PD™ International Conference
Cellular Senescence As A Pathogenic Contributor And Therapeutic Target In Alzheimer’s Disease
FEATURING
Miranda E. Orr
- 150 views
- October 23, 2023
- 1
AD/PD™ International Conference
Development of Treatment With Small Molecules for Alzheimer Disease
FEATURING
Pavel Pavlov
- 142 views
- October 23, 2023
AD/PD™ International Conference
The Early Cellular Responses in the Alzheimer Disease Brain
FEATURING
Bart De Strooper
- 25 views
- October 20, 2023
AD/PD™ International Conference
The Amyloid Scaffold Hypothesis
FEATURING
Todd E. Golde
- 10 views
- October 20, 2023
AD/PD™ International Conference
Cryo-Em Structures of Amyloids from Human Brain
FEATURING
Sjors H. Scheres
- 6 views
- October 20, 2023
AD/PD™ International Conference
A 56-KDA SDS-Stable, Soluble, Non-Plaque-Related, Brain-Derived Oligomer Comprised of Canonical AB40
FEATURING
Karen H. Ashe
- 3 views
- October 20, 2023
AD/PD™ International Conference
GM1 Promotes Early AB42 Oligomer Formation and Maintenance
FEATURING
Nikolay V. Dokholyan
- 2 views
- October 20, 2023
AD/PD™ International Conference
The Dense-Core Plaques of Alzheimer's Disease Are Granulomas
FEATURING
Greg Lemke
- 7 views
- October 20, 2023
AD/PD™ International Conference
Tau Immunotherapy: Intracellular Or Extracellular Target?
FEATURING
Luc Buée
- 11 views
- October 20, 2023
AD/PD™ International Conference
The First Disease-Modifying Treatments for AD: A Glass Half Full
FEATURING
Dennis Selkoe
- 289 views
- October 17, 2023
AD/PD™ International Conference
CSF and Blood Biomarkers for AD - Pathophysiology, Diagnostic Algorithms and Therapy Monitoring
FEATURING
Kaj Blennow
- 228 views
- October 17, 2023
AD/PD™ International Conference
Phase 1 Preventive Adjuvanted Tau Vaccine, AV-1980R
FEATURING
Lon Schneider
- 121 views
- October 17, 2023
AD/PD™ International Conference
Disease Modifiers for AD - A Regulatory Perspective
FEATURING
Yaning Wang
- 22 views
- October 17, 2023